Ulteriori informazioni
Informationen zum Autor Nathan D. Wong, PhD, FACC, FAHA, FNLA , is Director, UCI Heart Disease Prevention Program, Professor, Department of Internal Medicine at the University of California Irvine School of Medicine, Irvine, California. He is also Past President, American Society for Preventive Cardiology. Klappentext Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations, novel risk factors, and psychosocial stress. Throughout the Manual, recommendations are based on the most recent prevention guidelines of the American College of Cardiology and American Heart Association, including those on Risk Assessment, Lifestyle Recommendations, Blood Cholesterol, and Obesity, as well as the new guidelines on Hypertension. Chapter authors are recognized leaders in each area of practice, and special efforts have been made by the authors and editors to ensure that the content of all chapters is as up-to-date as possible. Key Features: Presents a highly practical focus on the application of current guidelines and practice standards regarding cardiovascular risk factors Recommendations based on the most recent prevention guidelines Authored by recognized leaders in the field Covers all major cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations Inhaltsverzeichnis Contents Contributors Foreword Thomas A. Pearson, MD, MPH, PhD Preface Acknowledgments 1. National Burden of Cardiovascular Disease and Associated Risk Factors Jamal S. Rana, MD, PhD Alan S. Go, MD 2. Cardiovascular Risk Assessment Andre R. M. Paixao, MD Jarrett D. Berry, MD, MS 3. The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence Neil J. Stone, MD, MACP, FACC, FAHA 4. Management of High Blood Pressure William J. Elliott, MD, PhD 5. Smoking and Passive Smoking Russell V. Luepker, MD, MS 6. Metabolic Syndrome Nirmal Sunkara, MD Shaista Malik, MD, PhD, MPH 7. Diabetes Management Guidelines Donna M. Polk, MD, MPH 8. Assessment and Management of Obesity Rohini J. Patel, MPH Stanley Bassin, EdD 9. Novel Biomarkers and Risk Factors Henry G. Cheng, MD Seth S. Martin, MD Steven R. Jones, MD 10. Antithrombotic Therapy in the Primary and Secondary Prevention of Cardiovascular Disease Terence Hill, MD Ty J. Gluckman, MD, FACC, FAHA Jessica L. Mega, MD, MPH, FACC, FAHA Omair K. Yousuf, MD 11. Psychosocial Risk Factors for Cardiovascular Disease Alan Rozanski, MD, FACC 12. Role of Stress Testing Amil M. Shah, MD, MPH Samia Mora, MD, MHS 13. Role of Carotid Intima-Media Thickness Assessment in Preventative Cardiology Eric Y. Yang, MD Vijay Nambi, MD, PhD 14. Role of Noncontrast Coronary CT for Detection of Coronary Heart Disease and Cardio...
